RHY 0.00% 4.7¢ rhythm biosciences limited

Bescreened 10,000 patient tests /trial, page-13

  1. 3,586 Posts.
    lightbulb Created with Sketch. 338
    Colon Cancer Blood Test (BeScreened™-CRC) | My Lab ReQuest (sonoraquest.com)

    Price is not the selling point for the above mentioned product.

    The attraction for the RHY offering is not only effectiveness and accuracy but, drum roll, price. RHY offers a product that, if approved etc, claims to be price attractive to medical professionals and insurers etc. The other product is more expensive but an alternative to the FIT etc.

    Something like that.

    We are not investing in something that hopes to fill a niche- we are looking to disrupt.

    IMHO DYOR
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.